Incidence and risk factors of severe adverse events with nevirapine-based antiretroviral therapy in HIV-infected women. MTCT-Plus program, Abidjan, Côte d'Ivoire

BACKGROUND: In resource-limited settings where nevirapine-containing regimen is the preferred regimen in women, data on severe adverse events (SAEs) according to CD4 cell count are limited. We estimated the incidence of SAEs according to CD4 cell count and identify their risk factors in nevirapine-t...

Descripción completa

Detalles Bibliográficos
Autores principales: Coffie, Patrick A, Tonwe-Gold, Besigin, Tanon, Aristophane K, Amani-Bosse, Clarisse, Bédikou, Gédéon, Abrams, Elaine J, Dabis, François, Ekouevi, Didier K
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2904297/
https://www.ncbi.nlm.nih.gov/pubmed/20576111
http://dx.doi.org/10.1186/1471-2334-10-188

Ejemplares similares

Ejemplares similares